Identification of telomere dysfunction in Friedreich ataxia.


Autoria(s): Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, S; Yasaei, H; Giunti, P; Slijepcevic, P; Pook, M
Data(s)

19/07/2016

01/06/2015

19/07/2016

2015

Resumo

Background: Friedreich ataxia (FRDA) is a progressive inherited neurodegenerative disorder caused by mutation of the FXN gene, resulting in decreased frataxin expression, mitochondrial dysfunction and oxidative stress. A recent study has identified shorter telomeres in FRDA patient leukocytes as a possible disease biomarker. Results: Here we aimed to investigate both telomere structure and function in FRDA cells. Our results confirmed telomere shortening in FRDA patient leukocytes and identified similar telomere shortening in FRDA patient autopsy cerebellar tissues. However, FRDA fibroblasts showed significantly longer telomeres at early passage, occurring in the absence of telomerase activity, but with activation of an alternative lengthening of telomeres (ALT)-like mechanism. These cells also showed accelerated telomere shortening as population doubling increases. Furthermore, telomere dysfunction-induced foci (TIF) analysis revealed that FRDA fibroblasts have dysfunctional telomeres. Conclusions: Our finding of dysfunctional telomeres in FRDA cells provides further insight into FRDA molecular disease mechanisms, which may have implications for future FRDA therapy.

This work was supported by funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement number 242193/EFACTS (CS) and the Wellcome Trust [089757] (SA) to MAP. PG is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.

Identificador

Molecular Neurodegeneration, 10:22, (2015)

1750-1326

http://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-015-0019-6

http://bura.brunel.ac.uk/handle/2438/12968

http://dx.doi.org/10.1186/s13024-015-0019-6

Idioma(s)

en

Publicador

Biomed Central

Relação

Mol. Neurodegen

Palavras-Chave #Friedreich ataxia #FRDA #Frataxin #FXN #GAA repeat expansion #Mouse model #Alternative lengthening of telomeres #ALT #Telomere dysfunction
Tipo

Article